Indietro

Poster

Vaccines

P 189
Strategies based on nudging to reduce vaccine hesitancy in PLWHA in a northern Italy center
Abstract
Poster
P 190
Vaccine uptake pre and post COVID-19 pandemic among PLWH
Abstract
Poster
P 191
A systematic and evidence-based approach in vaccination of people living with HIV: the Notebook of Clinical Vaccinology
Abstract
Poster
Commento
P 192
Antibody and Interferon response in HIV patients following mRNA-based SARS-CoV-2 vaccine
Abstract
Poster
Commento
P 193
Evaluation of functional antibodies against HIV Env and Tat proteins: analysis of antibody-dependent cell-mediated cytotoxicity (ADCC)
Abstract
Poster
Commento
P 194
Correlation between immune response and adverse events in MS patients after Shingrix vaccine administration
Abstract
Poster
P 195
Evaluation of cell-mediated Immunity to HPV nonavalent vaccine (Gardasil9®) in a cohort of people living with HIV
Abstract
Poster
P 196
PrEP access highlights worrisome gap in vaccination coverage against HPV and other vaccine preventable STIs
Abstract
Poster
P 197
Lactoferrin assumption in vaccinated subjects infected by Sars-CoV-2 may influence time length of negativization
Abstract
Poster
P 198
Analysis of Spike-specific immunity induced by IDLV-Spike in mice: comparison between females and males
Abstract
Poster
Commento
P 199
Neutralizing antibodies titers against ten viral Spike protein variants of SARS-CoV-2 in the serum of patients receiving dialysis before and 30 days after the XBB1.5 updated mRNA vaccination
Abstract
Poster
Commento
P 200
Neutralizing antibody response to the highly divergent BA.2.86 SARS-CoV-2 lineages in vaccinated health care workers with or without subsequent infection
Abstract
Poster
Commento
P 201
Hepatitis A virus protection status in cis males and transgender females who live with HIV and have sex with men: a retrospective observational study
Abstract
Poster
Commento
P 202
Beyond the barriers: the impact of HPV vaccination program variation among MSM PLWH
Abstract
Poster
Commento
P 203
Varicella Zoster Virus Vaccination in immunocompromised patients with haematological and rheumatological diseases: specific T-cell response measured with an in-house Interferon Gamma Release Assay
Abstract
Poster
Commento
P 204
Behavioral and epidemiological survey on compliance to receive new booster doses of anti-SARS-Cov2 vaccine in PLWH
Abstract
Poster
Commento
P 205
Specific T-cell responses to Varicella Zoster Virus glycoprotein E one year after vaccination with a recombinant adjuvanted subunit vaccine in people with multiple sclerosis on disease modifying treatments
Abstract
Poster
| Privacy policy | Cookies policy | Termini e condizioni di utilizzo |
© Effetti srl
P. IVA 10756900154
×

Commento audio

Chiudi